ACT-A Therapeutics Pillar is inviting pharmaceutical manufacturers and interested stakeholders to a webinar

The webinar will be an opportunity to provide an update on ACT-A and the different mechanisms that the Therapeutics Pillar is putting in place to support the successful uptake by countries of therapeutics for COVID-19 as they are recommended.

We will provide a recap of the ACT-A Therapeutics Pillar (co-led by Unitaid and Wellcome), its structure and objectives; present a high level overview of the pipeline and estimated projections for need across use cases; provide an update from WHO on regulatory/normative processes; and share current thinking on possible procurement channels by the Global Fund and Unicef for new therapeutics in anticipation of potential approval for use in COVID-19.

Upon registration, you will be able to save a calendar invite for this event.